<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2007-09-11" updated="2020-01-02">
  <drugbank-id primary="true">DB04815</drugbank-id>
  <name>Clioquinol</name>
  <description>Clioquinol was withdrawn in 1983 due to neurotoxicity.</description>
  <cas-number>130-26-7</cas-number>
  <unii>7BHQ856EJ5</unii>
  <average-mass>305.5</average-mass>
  <monoisotopic-mass>304.910434914</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>vet_approved</group>
    <group>withdrawn</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A2698</ref-id>
        <pubmed-id>185949</pubmed-id>
        <citation>Rohde W, Mikelens P, Jackson J, Blackman J, Whitcher J, Levinson W: Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus. Antimicrob Agents Chemother. 1976 Aug;10(2):234-40.</citation>
      </article>
      <article>
        <ref-id>A2699</ref-id>
        <pubmed-id>14162901</pubmed-id>
        <citation>GHOLZ LM, ARONS WL: PROPHYLAXIS AND THERAPY OF AMEBIASIS AND SHIGELLOSIS WITH IODOCHLORHYDROXYQUIN. Am J Trop Med Hyg. 1964 May;13:396-401.</citation>
      </article>
      <article>
        <ref-id>A2700</ref-id>
        <pubmed-id>15651505</pubmed-id>
        <citation>Kager PA: [Outbreak of amoebiasis in a Dutch family; tropics unexpectedly nearby]. Ned Tijdschr Geneeskd. 2005 Jan 1;149(1):51-2; author reply 52-3.</citation>
      </article>
      <article>
        <ref-id>A2701</ref-id>
        <pubmed-id>15074181</pubmed-id>
        <citation>Bosman DK, Benninga MA, van de Berg P, Kooijman GC, van Gool T: [Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children]. Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):575-9.</citation>
      </article>
      <article>
        <ref-id>A2702</ref-id>
        <pubmed-id>226725</pubmed-id>
        <citation>Masters DK, Hopkins AD: Therapeutic trial of four amoebicide regimes in rural Zaire. J Trop Med Hyg. 1979 May;82(5):99-101.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Used as a topical antifungal treatment.</indication>
  <pharmacodynamics>Clioquinol is a broad-spectrum antibacterial with antifungal properties. Application of clioquinol to extensive or eroded areas of the skin may lead to increased protein-bound iodine (PBI) levels within 1 week. In addition, elevated PBI levels may occur when relatively small areas of the skin are treated with clioquinol for more than 1 week.</pharmacodynamics>
  <mechanism-of-action>Clioquinol is bacteriostatic, however, the precise mechanism of its action is unknown.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption>Topical absorption is rapid and extensive, especially when the skin is covered with an occlusive dressing or if the medication is applied to extensive or eroded areas of the skin. Clioquinol is absorbed through the skin in sufficient amounts to affect thyroid function tests. </absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as chloroquinolines. These are compounds containing a quinoline moiety, which carries one or more chlorine atoms.</description>
    <direct-parent>Chloroquinolines</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Quinolines and derivatives</class>
    <subclass>Haloquinolines</subclass>
    <alternative-parent>8-hydroxyquinolines</alternative-parent>
    <alternative-parent>Aryl chlorides</alternative-parent>
    <alternative-parent>Aryl iodides</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>O-iodophenols</alternative-parent>
    <alternative-parent>Organochlorides</alternative-parent>
    <alternative-parent>Organoiodides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organooxygen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Pyridines and derivatives</alternative-parent>
    <substituent>2-iodophenol</substituent>
    <substituent>8-hydroxyquinoline</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Aryl chloride</substituent>
    <substituent>Aryl halide</substituent>
    <substituent>Aryl iodide</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Chloroquinoline</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organochloride</substituent>
    <substituent>Organohalogen compound</substituent>
    <substituent>Organoiodide</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Pyridine</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="german" coder="">5-Chlor-7-jod-8-hydroxy-chinolin</synonym>
    <synonym language="english" coder="">5-Chloro-7-iodo-8-hydroxyquinoline</synonym>
    <synonym language="english" coder="">5-Chloro-7-iodo-8-quinolinol</synonym>
    <synonym language="english" coder="iupac">5-chloro-7-iodoquinolin-8-ol</synonym>
    <synonym language="english" coder="">5-Chloro-8-hydroxy-7-iodoquinoline</synonym>
    <synonym language="english" coder="">7-Iodo-5-chloro-8-hydroxyquinoline</synonym>
    <synonym language="english" coder="">7-Iodo-5-chloroxine</synonym>
    <synonym language="english" coder="">Chloroiodoquin</synonym>
    <synonym language="english/spanish" coder="inn">Clioquinol</synonym>
    <synonym language="latin" coder="inn">Clioquinolum</synonym>
    <synonym language="english" coder="">Iodochlorhydroxyquin</synonym>
    <synonym language="english" coder="">Iodochlorhydroxyquinoline</synonym>
    <synonym language="english" coder="">Iodochlorohydroxyquin</synonym>
    <synonym language="english" coder="">Iodochloroxyquinoline</synonym>
  </synonyms>
  <products>
    <product>
      <name>Ala Quin</name>
      <labeller>Crown Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0316-0123</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1970-08-19</started-marketing-on>
      <ended-marketing-on>2021-11-30</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aristoform R Crm 0.1%</name>
      <labeller>Lederle Cyanamid Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00128058</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1966-12-31</started-marketing-on>
      <ended-marketing-on>1997-01-29</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dermasorb AF Complete Kit</name>
      <labeller>Crown Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0316-1025</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-14</started-marketing-on>
      <ended-marketing-on>2018-01-02</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Dermoscribe Diaper</name>
      <labeller>Dermoscribe Pty Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>69683-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part348</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Dermoscribe Ichybum</name>
      <labeller>Xlma Pty Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>69683-101</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part348</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Locacorten Vioform</name>
      <labeller>Paladin Labs Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074462</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1968-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Locacorten Vioform</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074470</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1968-12-31</started-marketing-on>
      <ended-marketing-on>1998-05-08</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Locacorten Vioform Eardrops</name>
      <labeller>Paladin Labs Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074454</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo Vagex</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00147591</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1964-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Vaginal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Phen-oris - Ont Top</name>
      <labeller>Germiphene Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02181150</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-12-04</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Phenoris Ont</name>
      <labeller>E L Stickley And Co Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00428078</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1998-12-07</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PMS-flumethasone-clioquinol</name>
      <labeller>Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242737</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <labeller>SmartPractice Denmark ApS</labeller>
      <ndc-id/>
      <ndc-product-code>67334-0457</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Cutaneous</route>
      <fda-application-number>BLA103738</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vioform + Hydrocortisone</name>
      <labeller>Geigy Pharmaceuticals, Ciba Geigy Canada Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074527</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1959-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-23</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vioform 3%</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00005142</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1951-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-04</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vioform 3%</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00005797</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1910-12-31</started-marketing-on>
      <ended-marketing-on>1999-04-15</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vioform Hydrocortisone</name>
      <labeller>Paladin Labs Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074500</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1957-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vioform Hydrocortisone Mild</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00074489</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1961-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-04</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <ingredients>2-mercaptobenzothiazole + 2,2'-Dibenzothiazyl disulfide + 4-(Isopropylamino)diphenylamine + alpha-Amyl cinnamaldehyde + Bacitracin + Balsam of Peru + Benzocaine + Benzylparaben + Bisphenol A diglycidyl ether + Bromothalonil + Bronopol + Budesonide + Butylparaben + Chlorquinaldol + Cinchocaine + Cinnamaldehyde + Cinnamyl alcohol + Clioquinol + Cobalt chloride + Diazolidinylurea + Dichromate + Dipentamethylenethiuram disulfide + Diphenylguanidine + Disperse Blue 106 + Disulfiram + Ditiocarb Zinc + Ethyl hydroxybenzoate + Ethylenediamine + Eugenol + Evernia prunastri + Formaldehyde + Geraniol + Hydrocortisone butyrate + Hydroxycitronellal + Imidurea + Isoeugenol + Lanolin alcohols + Methylchloroisothiazolinone + Methylparaben + Morpholinylmercaptobenzothiazole + N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine + N,N'-diphenyl-1,4-phenylenediamine + Neomycin + Nickel sulfate + p-Phenylenediamine + P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight) + Parthenolide + Propylparaben + Quaternium-15 + Rosin + Sodium aurotiosulfate + Tetracaine + Tetramethylthiuram monosulfide + Thimerosal + Thiohexam + Thiram + Tixocortol + Zinc Dibutyldithiocarbamate</ingredients>
    </mixture>
    <mixture>
      <name>Dermasorb AF Complete Kit</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Dermoscribe Diaper</name>
      <ingredients>Clioquinol + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Dermoscribe Ichybum</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Ala Quin</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Locacorten Vioform</name>
      <ingredients>Clioquinol + Flumethasone</ingredients>
    </mixture>
    <mixture>
      <name>Vioform Hydrocortisone</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Locacorten Vioform Eardrops</name>
      <ingredients>Clioquinol + Flumethasone</ingredients>
    </mixture>
    <mixture>
      <name>Neo Vagex</name>
      <ingredients>Acetarsol + Benzalkonium + Clioquinol</ingredients>
    </mixture>
    <mixture>
      <name>Phenoris Ont</name>
      <ingredients>Allantoin + Clioquinol + Phenol</ingredients>
    </mixture>
    <mixture>
      <name>Phen-oris - Ont Top</name>
      <ingredients>Allantoin + Clioquinol + Phenol</ingredients>
    </mixture>
    <mixture>
      <name>Locacorten Vioform</name>
      <ingredients>Clioquinol + Flumethasone</ingredients>
    </mixture>
    <mixture>
      <name>Vioform 3%</name>
      <ingredients>Clioquinol</ingredients>
    </mixture>
    <mixture>
      <name>Vioform 3%</name>
      <ingredients>Clioquinol</ingredients>
    </mixture>
    <mixture>
      <name>Vioform + Hydrocortisone</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Vioform Hydrocortisone Mild</name>
      <ingredients>Clioquinol + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Aristoform R Crm 0.1%</name>
      <ingredients>Clioquinol + Triamcinolone</ingredients>
    </mixture>
    <mixture>
      <name>PMS-flumethasone-clioquinol</name>
      <ingredients>Clioquinol + Flumethasone</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antiparasitic Products, Insecticides and Repellents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiprotozoals</category>
      <mesh-id>D000981</mesh-id>
    </category>
    <category>
      <category>Antiseptics and Disinfectants</category>
      <mesh-id/>
    </category>
    <category>
      <category>Cell-mediated Immunity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Genito Urinary System and Sex Hormones</category>
      <mesh-id/>
    </category>
    <category>
      <category>Gynecological Antiinfectives and Antiseptics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Hydroxyquinoline Derivatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Hydroxyquinolines</category>
      <mesh-id>D006912</mesh-id>
    </category>
    <category>
      <category>Increased Histamine Release</category>
      <mesh-id/>
    </category>
    <category>
      <category>Medicated Dressings</category>
      <mesh-id/>
    </category>
    <category>
      <category>Medicated Dressings With Antiinfectives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Miscellaneous Antifungals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Otologicals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Quinoline Derivatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Quinolines</category>
      <mesh-id>D011804</mesh-id>
    </category>
    <category>
      <category>Sensory Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Standardized Chemical Allergen</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Kit</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Auricular (otic)</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Vaginal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Cutaneous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="G01AC02">
      <level code="G01AC">Quinoline derivatives</level>
      <level code="G01A">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</level>
      <level code="G01">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</level>
      <level code="G">GENITO URINARY SYSTEM AND SEX HORMONES</level>
    </atc-code>
    <atc-code code="S02AA05">
      <level code="S02AA">Antiinfectives</level>
      <level code="S02A">ANTIINFECTIVES</level>
      <level code="S02">OTOLOGICALS</level>
      <level code="S">SENSORY ORGANS</level>
    </atc-code>
    <atc-code code="D09AA10">
      <level code="D09AA">Medicated dressings with antiinfectives</level>
      <level code="D09A">MEDICATED DRESSINGS</level>
      <level code="D09">MEDICATED DRESSINGS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
    <atc-code code="P01AA02">
      <level code="P01AA">Hydroxyquinoline derivatives</level>
      <level code="P01A">AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES</level>
      <level code="P01">ANTIPROTOZOALS</level>
      <level code="P">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</level>
    </atc-code>
    <atc-code code="P01AA52">
      <level code="P01AA">Hydroxyquinoline derivatives</level>
      <level code="P01A">AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES</level>
      <level code="P01">ANTIPROTOZOALS</level>
      <level code="P">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</level>
    </atc-code>
    <atc-code code="D08AH30">
      <level code="D08AH">Quinoline derivatives</level>
      <level code="D08A">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D08">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>84:04.08.92</ahfs-code>
  </ahfs-codes>
  <pdb-entries>
    <pdb-entry>3kcx</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>3.66</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-3.1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.64e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>3.36</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>5-chloro-7-iodoquinolin-8-ol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>clioquinol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>305.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>304.910434914</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OC1=C(I)C=C(Cl)C2=C1N=CC=C2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C9H5ClINO</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>QCDFBFJGMNKBDO-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>33.12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>60.13</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>22.63</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>7.34</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>3.28</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>178.5 Â°C</value>
      <source>PhysProp</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>9081</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>74460</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>2788</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46509081</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>2686</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>32188</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449039</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>CQL</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Clioquinol</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL497</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/mtm/clioquinol-topical.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>